Divider.png

Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes.

Introducing the VELscope Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that uses natural tissue fluorescence visualization to help discover oral mucosal abnormalities that might otherwise have been overlooked.

The VELscope® Vx adjunctive device is effective for the enhanced visualization of oral mucosal abnormalities.

The VELscope® Vx adjunctive device is effective for the enhanced visualization of oral mucosal abnormalities.

Cleared by the FDA and the World Health Organization, the award-winning VELscope Vx is the world’s most widely used adjunctive device for the discovery of:

  • Viral, fungal and bacterial infections

  • Inflammation from a variety of causes (allergy to amalgam fillings, etc.)

  • Squamous papillomas

  • Salivary gland tumors

  • Cancer and pre-cancer

  • Other oral mucosal conditions

Traditional risk factors of
oral cancer include:

  • Previous history of oral cancer

  • Over 40 years of age

  • Alcohol 

  • Smoking

  • Smokeless tobacco

  • HPV

More than 25 million VELscope Vx examinations have been performed by over 12,000 dental practitioners in 23 countries. The technology is also backed by more clinical studies than any other adjunctive device for tissue fluorescence visualization.